Daiichi Life Insurance Co. Ltd. Makes New $6.20 Million Investment in Danaher Corporation $DHR

Daiichi Life Insurance Co. Ltd. bought a new position in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 8,608 shares of the conglomerate’s stock, valued at approximately $6,198,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. acquired a new position in Danaher during the second quarter worth approximately $10,492,520,000. Norges Bank purchased a new stake in Danaher in the fourth quarter valued at approximately $2,177,106,000. Generation Investment Management LLP purchased a new stake in Danaher in the second quarter valued at approximately $1,287,949,000. Flossbach Von Storch SE acquired a new stake in shares of Danaher in the second quarter valued at approximately $747,260,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Danaher during the second quarter worth approximately $712,875,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent research reports. DZ Bank began coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price on the stock. TD Cowen decreased their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. Guggenheim dropped their price objective on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Finally, Piper Sandler began coverage on shares of Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Stock Up 1.6%

Shares of Danaher stock opened at $219.42 on Friday. The company has a market cap of $154.25 billion, a P/E ratio of 38.97, a PEG ratio of 2.72 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The firm has a fifty day moving average of $195.80 and a two-hundred day moving average of $192.61.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter last year, the business earned $0.77 EPS. The business’s revenue was up 5.5% on a year-over-year basis. On average, analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.